216 related articles for article (PubMed ID: 22901226)
1. ER81-shRNA inhibits growth of triple-negative human breast cancer cell line MDA-MB-231 in vivo and in vitro.
Chen Y; Zou H; Yang LY; Li Y; Wang L; Hao Y; Yang JL
Asian Pac J Cancer Prev; 2012; 13(5):2385-92. PubMed ID: 22901226
[TBL] [Abstract][Full Text] [Related]
2. Dipyridamole prevents triple-negative breast-cancer progression.
Spano D; Marshall JC; Marino N; De Martino D; Romano A; Scoppettuolo MN; Bello AM; Di Dato V; Navas L; De Vita G; Medaglia C; Steeg PS; Zollo M
Clin Exp Metastasis; 2013 Jan; 30(1):47-68. PubMed ID: 22760522
[TBL] [Abstract][Full Text] [Related]
3. BTG2 inhibits the proliferation, invasion, and apoptosis of MDA-MB-231 triple-negative breast cancer cells.
Zhang YJ; Wei L; Liu M; Li J; Zheng YQ; Gao Y; Li XR
Tumour Biol; 2013 Jun; 34(3):1605-13. PubMed ID: 23420441
[TBL] [Abstract][Full Text] [Related]
4. [Effects of FBI-1 silencing on proliferation and apoptosis of triple-negative breast cancer cell line MDA-MB-231].
Chen MJ; Wang L; Yang WP; Qin QH; Tan QX; Lian B; Wei CY
Sheng Li Xue Bao; 2018 Oct; 70(5):497-503. PubMed ID: 30377688
[TBL] [Abstract][Full Text] [Related]
5. Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat.
Tate CR; Rhodes LV; Segar HC; Driver JL; Pounder FN; Burow ME; Collins-Burow BM
Breast Cancer Res; 2012 May; 14(3):R79. PubMed ID: 22613095
[TBL] [Abstract][Full Text] [Related]
6. Targeting of COX-2 expression by recombinant adenovirus shRNA attenuates the malignant biological behavior of breast cancer cells.
Tu B; Ma TT; Peng XQ; Wang Q; Yang H; Huang XL
Asian Pac J Cancer Prev; 2014; 15(20):8829-36. PubMed ID: 25374215
[TBL] [Abstract][Full Text] [Related]
7. Oral administration of penta-O-galloyl-β-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition.
Lee HJ; Seo NJ; Jeong SJ; Park Y; Jung DB; Koh W; Lee HJ; Lee EO; Ahn KS; Ahn KS; Lü J; Kim SH
Carcinogenesis; 2011 Jun; 32(6):804-11. PubMed ID: 21289371
[TBL] [Abstract][Full Text] [Related]
8. [Establishment of a bioluminescent MDA-MB-231 cell line for in vivo imaging of human triple-negative breast cancer xenograft].
Wang K; Xie SM; He JJ; Ren Y; Xia HB; Zhang XW
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1812-8. PubMed ID: 22126756
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a bioluminescent MDA-MB-231 cell line for human triple-negative breast cancer research.
Wang K; Xie S; Ren Y; Xia H; Zhang X; He J
Oncol Rep; 2012 Jun; 27(6):1981-9. PubMed ID: 22446691
[TBL] [Abstract][Full Text] [Related]
10. Expression of the PEA3 group of ETS-related transcription factors in human breast-cancer cells.
Baert JL; Monté D; Musgrove EA; Albagli O; Sutherland RL; de Launoit Y
Int J Cancer; 1997 Mar; 70(5):590-7. PubMed ID: 9052761
[TBL] [Abstract][Full Text] [Related]
11. Expression and regulatory function of miRNA-182 in triple-negative breast cancer cells through its targeting of profilin 1.
Liu H; Wang Y; Li X; Zhang YJ; Li J; Zheng YQ; Liu M; Song X; Li XR
Tumour Biol; 2013 Jun; 34(3):1713-22. PubMed ID: 23430586
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy.
Girgert R; Emons G; Gründker C
Breast Cancer Res Treat; 2012 Jul; 134(1):199-205. PubMed ID: 22290080
[TBL] [Abstract][Full Text] [Related]
13. Growth inhibition and apoptosis of human B-cell lymphoma in vitro and in vivo by Bcl-2 short hairpin RNA.
Liu Y; Shen Y; Qin C; Shi Y; Rong G; Yu X
Oncol Rep; 2013 Jan; 29(1):244-52. PubMed ID: 23076380
[TBL] [Abstract][Full Text] [Related]
14. PEA-15 inhibits tumorigenesis in an MDA-MB-468 triple-negative breast cancer xenograft model through increased cytoplasmic localization of activated extracellular signal-regulated kinase.
Bartholomeusz C; Gonzalez-Angulo AM; Kazansky A; Krishnamurthy S; Liu P; Yuan LX; Yamasaki F; Liu S; Hayashi N; Zhang D; Esteva FJ; Hortobagyi GN; Ueno NT
Clin Cancer Res; 2010 Mar; 16(6):1802-11. PubMed ID: 20215547
[TBL] [Abstract][Full Text] [Related]
15. Gonadotropin-releasing hormone type II antagonist induces apoptosis in MCF-7 and triple-negative MDA-MB-231 human breast cancer cells in vitro and in vivo.
Gründker C; Föst C; Fister S; Nolte N; Günthert AR; Emons G
Breast Cancer Res; 2010; 12(4):R49. PubMed ID: 20630060
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716
[TBL] [Abstract][Full Text] [Related]
17. Targeting DNA replication before it starts: Cdc7 as a therapeutic target in p53-mutant breast cancers.
Rodriguez-Acebes S; Proctor I; Loddo M; Wollenschlaeger A; Rashid M; Falzon M; Prevost AT; Sainsbury R; Stoeber K; Williams GH
Am J Pathol; 2010 Oct; 177(4):2034-45. PubMed ID: 20724597
[TBL] [Abstract][Full Text] [Related]
18. Agonists and antagonists of GnRH-I and -II reduce metastasis formation by triple-negative human breast cancer cells in vivo.
Schubert A; Hawighorst T; Emons G; Gründker C
Breast Cancer Res Treat; 2011 Dec; 130(3):783-90. PubMed ID: 21279682
[TBL] [Abstract][Full Text] [Related]
19. Effects of miR-155 antisense oligonucleotide on breast carcinoma cell line MDA-MB-157 and implanted tumors.
Zheng SR; Guo GL; Zhai Q; Zou ZY; Zhang W
Asian Pac J Cancer Prev; 2013; 14(4):2361-6. PubMed ID: 23725141
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of Efp by DNA-modified small interfering RNA inhibits breast cancer cell proliferation and in vivo tumor growth.
Ueyama K; Ikeda K; Sato W; Nakasato N; Horie-Inoue K; Takeda S; Inoue S
Cancer Gene Ther; 2010 Sep; 17(9):624-32. PubMed ID: 20467453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
